CIK 0001783183 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 175.1 M | 682000 | ||
| Net income (USD) | -143.9 M | -129.1 M | ||
| Diluted EPS (USD/shares) | -3.03 | -3.93 | -3.89 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-08 | 4 | 4 | 2026-10-06 |
| 2026-09-29 | 8-K | 8-K items 8.01 | 2026-09-29 |
| 2026-09-08 | 4 | 4 | 2026-09-03 |
| 2026-07-30 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-30 | 8-K | 8-K items 2.02,9.01 | 2026-07-30 |
| 2026-07-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-20 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-16 | 4 | 4 | 2026-07-14 |
| 2026-06-23 | 8-K | 8-K items 8.01 | 2026-06-23 |
| 2026-05-27 | 4 | 4 | 2026-05-22 |
| 2026-05-21 | 4 | 4 | 2026-05-19 |
| 2026-05-21 | 4 | 4 | 2026-05-19 |
| 2026-05-21 | 4 | 4 | 2026-05-19 |
| 2026-05-21 | 4 | 4 | 2026-05-19 |
| 2026-05-21 | 4 | 4 | 2026-05-19 |
| 2026-05-21 | 4 | 4 | 2026-05-19 |
| 2026-05-21 | 4 | 4 | 2026-05-19 |
| 2026-05-21 | 8-K | 8-K items 5.07 | 2026-05-19 |
| 2026-04-30 | 10-Q | 10-Q | 2026-03-31 |
| 2026-04-30 | 8-K | 8-K items 2.02,9.01 | 2026-04-30 |
| 2026-04-07 | DEFA14A | DEFA14A | |
| 2026-04-07 | ARS | ARS | 2025-12-31 |
| 2026-04-07 | DEF 14A | DEF 14A | 2026-05-19 |
| 2026-03-27 | S-8 | S-8 | |
| 2026-03-12 | SCHEDULE 13G | SCHEDULE 13G |
Forms on file (last 1,000): 4 195, 8-K 99, 3 24, 10-Q 21, SC 13G/A 20, SC 13D/A 15, SC 13G 13, SCHEDULE 13G/A 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PHAT (0.002 USD), /gw/filings/filings?ticker=PHAT&form=8-K, /gw/filings/facts?ticker=PHAT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange